Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Neoprobe Corp. (NEOP) Neoprobe Corp. (NEOP) licensed three cancer-targeting agents for
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury